Randomized Phase II Study of Everolimus (E) versus Everolimus plus Bevacizumab (E+B) in Patients (Pts) with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)

Kulke, Matthew H. ,  Niedzwiecki, Donna ,  Foster, Nathan R. ... -  NANETS -  Pancreas -  2016  

Abstract -  Primary Endpoint -  Primary Analysis -  GI -  CALGB-80701